Exploring Digital Engagement Strategies for Addressing Identity Challenges in Young South African Women and Girls (16–24) Living with HIV: A Thematic and Sociological Analysis
By
SunHa Ahn
May 12, 2026
Clinical Report: Digital Engagement Strategies for Young South African Women with HIV
Overview {'add': 'Specify the digital platforms discussed, such as Springster.'}
Background {'add': 'Include specific statistics on HIV infection rates among young women.'}
Data Highlights {'remove': 'The statement about the absence of numerical data.'}
Key Findings {'add': 'Link findings to specific methodologies used in the study.'}
Clinical Implications {'expand': 'Provide examples of how to integrate digital strategies into existing programs.'}
Conclusion {'expand': 'Discuss implications for future research or policy.'}
Related Resources & Content
Mbotwa et al., Digital Health, 2023 -- Privacy, stigma, and bio-power: The potential of digital applications in HIV prevention services in the Indonesian context
The Journal of Infectious Diseases, 2023 -- Elevated Rates and Genetic Variation of Ongoing Chlamydia Trachomatis Infections in South African Adolescent Girls and Young Women: Insights from Two Urban Areas
Open Forum Infectious Diseases, 2023 -- Exploring the Impact of Hidden Stigma Profiles on HIV Treatment and Care Outcomes in Women Living with HIV in the United States: An Intersectional Perspective
Open Forum Infectious Diseases, 2023 -- Outcomes of HIV Care Continuum in Latin American and Caribbean Adolescents and Young Adults: Links to Depression and Substance Use
National ART Clinical Guideline, 2023 -- South Africa’s current ART standard for adolescents and adults
Open Forum Infectious Diseases, 2023 -- Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens
WHO, 2023 -- WHO guideline on HIV service delivery
https://knowledgehub.health.gov.za/system/files/elibdownloads/2023-07/National%20ART%20Clinical%20Guideline%20AR%204.5%2020230713%20Version%204%20WEB.pdf
Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens | Open Forum Infectious Diseases | Oxford Academic
WHO guideline on HIV service delivery